Reaction
Autonomic Neuropathy reporting signals
As of the last recalculation, Autonomic Neuropathy appears in 1,001 FAERS reports alongside 25 co-occurring drug terms. The strongest observed disproportionality signal is BORTEZOMIB (PRR 51.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Bortezomib | 181 | 51.2 | 51.3 |
| Rasagiline Mesylate | 13 | 24.6 | 24.6 |
| Ado-Trastuzumab Emtansine | 9 | 22.4 | 22.4 |
| Brentuximab Vedotin | 9 | 18.4 | 18.4 |
| Telmisartan | 14 | 16.5 | 16.5 |
| Pertuzumab | 21 | 16.4 | 16.4 |
| Drs. Clotrimazole | 9 | 16.3 | 16.3 |
| Family Wellness Clotrimazole | 9 | 16.3 | 16.3 |
| Clotrimazole Topical | 9 | 16.3 | 16.3 |
| Clotrimazole | 9 | 15.4 | 15.4 |
| Melphalan | 16 | 14.8 | 14.9 |
| Vincristine Sulfate | 20 | 14.5 | 14.5 |
| Melphalan Hydrochloride | 16 | 13.5 | 13.5 |
| Insulin Glargine-Yfgn | 13 | 12.5 | 12.5 |
| Ziprasidone Mesylate | 8 | 11.8 | 11.8 |
| Dexamethasone 1.5 Mg | 142 | 11.6 | 11.6 |
| Dexamethasone | 142 | 11.4 | 11.4 |
| Thalidomide | 18 | 10.4 | 10.4 |
| Bleomycin Sulfate | 5 | 10.1 | 10.1 |
| Daratumumab | 19 | 10.1 | 10.1 |
| Droxidopa | 9 | 8.7 | 8.7 |
| Tafamidis | 4 | 7.1 | 7.1 |
| Ixazomib | 9 | 6.6 | 6.6 |
| Axicabtagene Ciloleucel | 3 | 6.3 | 6.3 |
| Romosozumab-Aqqg | 3 | 4.6 | 4.6 |